Skip to main content
Presentation
EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL OVER 4 YEARS IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUT CONCOMITANT USE OF DMARDS. British Society for Rheumatology (BSR), Liverpool, May 2018.
British Society for Rheumatology (BSR) (2018)
  • R Cooper
  • J Walsh
  • Philip Mease, Providence St. Joseph Health
Disciplines
Publication Date
May, 2018
Citation Information
R Cooper, J Walsh and Philip Mease. "EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL OVER 4 YEARS IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUT CONCOMITANT USE OF DMARDS. British Society for Rheumatology (BSR), Liverpool, May 2018." British Society for Rheumatology (BSR) (2018)
Available at: http://works.bepress.com/philip-mease/148/